Epidemiology, impact, and experience of acne in transgender persons
Project Number5K23AR075888-05
Contact PI/Project LeaderYEUNG, HOWA
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY / ABSTRACT
The overall objective of this K23 proposal is to support new research training and experience crucial for the
candidate, Howa Yeung, MD MSc, to become an independent, patient-oriented investigator addressing sexual
and gender minority disparities in skin diseases – such as acne in transgender persons. Acne significantly
impairs health-related quality of life and is associated with depression, low self-esteem, and suicidal ideation.
Little is known about the interplay of endogenous and exogenous hormones on acne incidence, severity,
impact, treatment, and experience. Our prior studies noted higher acne prevalence associated with hormone
therapy and identified specific barriers for severe acne treatment in transgender persons. This proposal aims to
examine the epidemiology, impact, and experience of acne in the context of hormone therapy in transgender
persons – a health disparity population with significant knowledge gaps in skin health. The epidemiology of
acne will be examined using data from the existing large-scale, validated, multicenter Study of Transition,
Outcomes and Gender (STRONG). Factors that mediate differences in acne experience, treatment, and
research participation will be newly elicited using mixed methods. Development and pilot testing of a
recruitment protocol and collection of preliminary data on acne outcomes and mental health comorbidity will
help initiate a prospective cohort study of acne in transgender persons receiving hormone therapy. To achieve
these aims, the candidate will require additional training through a combination of formal didactics, practical
research experience, and expert multidisciplinary mentorship. The candidate will build expertise in sexual and
gender minority health and health disparities research, patient-oriented outcomes research in acne, mixed-
methods research techniques, as well as experience in community-engaged research and patient recruitment.
The candidate’s mentored training and research plans will enable him to launch a successful career as an
independent patient-oriented investigator addressing sexual and gender minority disparities in skin diseases –
such as acne in transgender persons. Key results will inform new acne and gender-affirming hormone
treatment paradigms and the design and implementation of future interventions, aimed to reduce the identified
acne disparities, optimize acne clinical outcomes, and to improve patient-centeredness of hormone therapy in
transgender persons.
Public Health Relevance Statement
PROJECT NARRATIVE
Acne significantly impairs quality of life and is associated with higher risks of mental health disorders. Little
is known about how internal and external hormones interact on the burden and outcomes of acne, particularly
for transgender persons requiring long-term hormone treatment. This proposal aims to identify and better
understand the burden, experience, and outcomes of acne with the ultimate goal to improve skin, mental
health, and quality of life outcomes from acne and hormone treatments.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcneAddressAdultAdverse effectsAgeAndrogensAnti-androgen TherapyAreaArthritisAsthmaBenefits and RisksBirthCaringCharacteristicsChronic DiseaseClinicalClinical Practice GuidelineClinical TrialsCollectionCutaneousDataData CollectionDevelopmentDiabetes MellitusDiagnosisDisparityEpidemiologyFeeling suicidalFeminizationFundingFutureGenderGender IdentityGoalsHealthHealth Disparities ResearchHealth StatusHealthcare SystemsHigh PrevalenceHormonalHormone useHormonesImpaired healthImpairmentIncidenceIndividualInterventionInterviewKnowledgeMeasuresMediatingMediatorMelanomaMental DepressionMental HealthMental disordersMentorsMentorshipMethodsModelingMulticenter StudiesNational Institute of Child Health and Human DevelopmentNational Institute on Minority Health and Health DisparitiesNatural HistoryOral ContraceptivesOutcomeOutcomes ResearchPathogenesisPatient RecruitmentsPatient-Focused OutcomesPatientsPersonsPopulationPrevalenceProspective StudiesProspective, cohort studyProtocols documentationPsoriasisQuality of lifeRaceResearchResearch MethodologyResearch PersonnelResearch TechnicsResearch TrainingRetrospective StudiesSeveritiesSexual and Gender MinoritiesSiteSkinSkin CarcinomaSurveysTechniquesTestosteroneTrainingWell in selfWomen's studycareerclinical practicecohortcommunity engaged researchcomorbiditycostdesigndisability burdendisparity reductionexperiencefuture implementationgender affirming hormone therapygender dysphoriagender minority groupgender minority healthgender minority health disparityhealth care disparityhealth care settingshealth disparity populationshealth related quality of lifehigh riskhormone therapyimprovedinterestmenminority disparityminority healthminority stressmultidisciplinarypatient orientedpilot testrecruitself esteemsexsexual minority groupsexual minority healthskin disordersocialtheoriestransfemininetransgendertransmasculine
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
20-August-2020
Project End Date
31-July-2025
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$157,788
Direct Costs
$146,100
Indirect Costs
$11,688
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$157,788
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K23AR075888-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K23AR075888-05
Patents
No Patents information available for 5K23AR075888-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K23AR075888-05
Clinical Studies
No Clinical Studies information available for 5K23AR075888-05
News and More
Related News Releases
No news release information available for 5K23AR075888-05
History
No Historical information available for 5K23AR075888-05
Similar Projects
No Similar Projects information available for 5K23AR075888-05